2026-03-13T08:17:09Zhttps://uvadoc.uva.es/oai/request

oai:uvadoc.uva.es:10324/429332021-09-27T09:41:43Zcom_10324_41462com_10324_954com_10324_894col_10324_41463

Mendoza, Carmen de Roc, Lourdes Benito, Rafael Reina, Gabriel Ramos, José Manuel Gómez, César Aguilera, Antonio Rodríguez Iglesias, Manuel García Costa, Juan Fernández Alonso, Mirian Soriano, Vicente 2020-10-13T11:56:11Z 2020-10-13T11:56:11Z 2019 BMC Infectious Diseases, 2019, vol.19, n. 1, art. 706 1471-2334 http://uvadoc.uva.es/handle/10324/42933 10.1186/s12879-019-4346-z 1 BMC Infectious Diseases 19 1471-2334 HTLV-1 infection is a neglected disease, despite infecting 10–15 million people worldwide and severe illnesses develop in 10% of carriers lifelong. Acknowledging a greater risk for developing HTLV-1 associated illnesses due to immunosuppression, screening is being widely considered in the transplantation setting. Herein, we report the experience with universal HTLV testing of donors and recipients of solid organ transplants in a survey conducted in Spain. eng info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by-nc-nd/4.0/ © BioMed Central Attribution-NonCommercial-NoDerivatives 4.0 Internacional HTLV-1 infection in solid organ transplant donors and recipients in Spain info:eu-repo/semantics/article